全文获取类型
收费全文 | 26649篇 |
免费 | 2520篇 |
国内免费 | 2002篇 |
专业分类
耳鼻咽喉 | 307篇 |
儿科学 | 235篇 |
妇产科学 | 277篇 |
基础医学 | 2981篇 |
口腔科学 | 349篇 |
临床医学 | 3318篇 |
内科学 | 3464篇 |
皮肤病学 | 216篇 |
神经病学 | 1430篇 |
特种医学 | 904篇 |
外国民族医学 | 9篇 |
外科学 | 3078篇 |
综合类 | 5500篇 |
现状与发展 | 4篇 |
预防医学 | 1769篇 |
眼科学 | 722篇 |
药学 | 3077篇 |
19篇 | |
中国医学 | 1621篇 |
肿瘤学 | 1891篇 |
出版年
2024年 | 21篇 |
2023年 | 329篇 |
2022年 | 608篇 |
2021年 | 1021篇 |
2020年 | 909篇 |
2019年 | 783篇 |
2018年 | 785篇 |
2017年 | 767篇 |
2016年 | 738篇 |
2015年 | 1146篇 |
2014年 | 1375篇 |
2013年 | 1397篇 |
2012年 | 2160篇 |
2011年 | 2008篇 |
2010年 | 1488篇 |
2009年 | 1218篇 |
2008年 | 1440篇 |
2007年 | 1527篇 |
2006年 | 1545篇 |
2005年 | 1489篇 |
2004年 | 1182篇 |
2003年 | 1290篇 |
2002年 | 1091篇 |
2001年 | 909篇 |
2000年 | 785篇 |
1999年 | 697篇 |
1998年 | 341篇 |
1997年 | 388篇 |
1996年 | 268篇 |
1995年 | 271篇 |
1994年 | 209篇 |
1993年 | 138篇 |
1992年 | 156篇 |
1991年 | 134篇 |
1990年 | 135篇 |
1989年 | 99篇 |
1988年 | 77篇 |
1987年 | 84篇 |
1986年 | 55篇 |
1985年 | 47篇 |
1984年 | 21篇 |
1983年 | 17篇 |
1982年 | 6篇 |
1981年 | 12篇 |
1980年 | 3篇 |
1979年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
随着人口老龄化进程的加速,脑小血管病(CSVD)的发病率也在不断上升,其导致的多种症状严重影响了患者的生活质量。MRI弥散张量成像(DTI)作为新近发展的影像技术,有无创显示白质纤维超微结构等优点,已被广泛用于疾病早期诊断、病情预测、治疗评估等多方面的研究。本文即就DTI技术在CSVD中的研究现状和未来发展前景进行综述。 相似文献
12.
Peng Zhong Jianye Peng Mingjie Yuan Bin Kong He Huang 《Scandinavian journal of immunology》2021,93(1)
Cold‐inducible RNA‐binding protein (CIRP) was previously identified as an intracellular stress‐response protein, which can respond to a variety of stress conditions by changing its expression and regulating mRNA stability through its binding site on the 3′‐UTR of its targeted mRNAs. Recently, extracellular CIRP (eCIRP) was discovered to be present in various inflammatory conditions and could act as a pro‐inflammatory factor. Genetic studies have demonstrated a key role for eCIRP in inflammatory conditions that led to the importance of targeting eCIRP in these diseases. Currently, the underlying mechanism of eCIRP‐induced inflammation is under intensive investigation and several signalling pathways are being explored. Here, we epitomized various signalling pathways that mediate the pro‐inflammatory effects of CIRP and also recapitulated all the CIRP‐derived peptides that can block the interaction between CIRP and its receptors in inflammatory setting. 相似文献
13.
Jim Zhong Michael Gallagher Chris Hounslow Gareth Iball Tze Wah 《Diagnostic and interventional radiology (Ankara, Turkey)》2021,27(2):244
PURPOSEWe aimed to evaluate the effect on the radiation dose to the patient by reducing the tube current during the placement of the ablation needles (reduced dose group) compared with the patient doses delivered when scanning at the standard fully diagnostic level (full dose group) in computed tomography (CT)-guided percutaneous cryoablation.METHODSWe conducted a retrospective study of 103 patients undergoing cryoablation in a tertiary cancer center. Overall, 62 patients were scanned with standard exposure parameters (full dose group) set on a 64-slice multidetector CT scanner, while 41 patients were scanned on a reduced dose protocol. Dose levels were retrieved from the hospital picture and archiving communication system including the volumetric CT dose index (CTDIvol), total dose length product (DLP), length of cryoablation procedure, number of cryoablation needles and patient size. Wilcoxon Mann-Whitney (rank-sum) tests were used to compare the median DLP, CTDIvol and skin dose between the two groups.RESULTSMedian total DLP for the full dose group was 6025 mGy·cm (1909–13353 mGy·cm) compared with 3391 mGy·cm (1683–6820 mGy·cm) for the reduced dose group. The reduced dose group had a 44% reduction in total DLP and 42% reduction in total CTDIvol (p < 0.001). The estimated skin doses were 384 mGy for the full dose group and 224 mGy for the reduced dose group (42% reduction) (p < 0.001). At 12-month follow-up, the technical success for the full dose (n=62) was 97% with 2 patients requiring a further cryoablation treatment for residual tumor. The technical success for the reduced dose group (n=41) was 100%.CONCLUSIONCT dose reduction technique during image-guided cryoablation treatment of renal tumors can achieve significant radiation dose reduction whilst maintaining sufficient image quality.Renal cell carcinoma is the most common kidney cancer and has a rising incidence (1–4), with obesity and smoking being major risk factors (5–8).Image-guided ablation offers a more minimally invasive option compared with surgery and the current evidence base shows that it is a safe and effective treatment for T1a tumors, with a low rate of complications (9–11). The major advantage of cryoablation over other modalities is the ability to accurately visualize the iceball and therefore zone of ablation on intraprocedural imaging, either with computed tomography (CT) or magnetic resonance imaging (MRI) (12, 13). However, renal cryoablation involves the placement of more ablation probes and can have almost three times the radiation exposure compared with CT-guided radiofrequency ablation procedures (14).In addition to this substantial radiation dose per cryoablation, estimated to be between 32 and 39.7 mSv, the follow-up CT imaging will also add to the total radiation burden (15, 16). Whilst this level of radiation dose and associated stochastic risk may be a lesser concern in the older patients, greater consideration needs to be given to younger patients (<50 years old) and in patients requiring lifelong follow-up imaging, in particular those with hereditary diseases such as Von Hippel-Lindau syndrome (15). To our knowledge, the potential for reducing radiation dose for cryoablation patients.The principle aim of this study was to evaluate the effect on the radiation dose to the patient by reducing the tube current during the placement of the ablation needles (reduced dose group) compared with the patient doses delivered when scanning at the standard fully diagnostic level (full dose group) in CT-guided percutaneous cryoablation. 相似文献
14.
Yang Luan Yan Zhang Kai Cui Fan Li Baolong Qin Yajun Ruan Kun Tang Hongyang Jiang Hao Li Xiaoyi Yuan Zhuo Liu Xiaming Liu Gan Yu Shengfei Xu Ruibao Chen Huan Yang Xiaolin Guo Xiaoyong Zeng Zhong Chen Zhiqiang Chen Zhiquan Hu Xiaodong Song Zhihua Wang Shaogang Wang Jihong Liu Tao Wang 《Translational andrology and urology》2021,10(1):466
BackgroundTo introduce and determine the value of optimized strategies for the management of urological tube-related emergencies with increased incidence, complexity and operational risk during the global spread of coronavirus disease 2019 (COVID-19).MethodsAll emergent urological patients at Tongji Hospital, Wuhan, during the period of January 23 (the beginning of lockdown in Wuhan) to March 23, 2020, and the corresponding period in 2019 were recruited to form this study’s COVID-19 group and control group, respectively. Tongji Hospital has the most concentrated and strongest Chinese medical teams to treat the largest number of severe COVID-19 patients. Patients in the control group were routinely treated, while patients in the COVID-19 group were managed following the optimized principles and strategies. The case incidence for each type of tube-related emergency was recorded. Baseline characteristics and management outcomes (surgery time, secondary complex operation rate, readmission rate, COVID-19 infection rate) were analyzed and compared across the control and COVID-19 periods.ResultsThe total emergent urological patients during the COVID-19 period was 42, whereas during the control period, it was 124. The incidence of tube-related emergencies increased from 53% to 88% (P<0.001) during the COVID-19 period. In particular, the incidence of nephrostomy tube-related (31% vs. 15%, P=0.027) and single-J stent-related problems (19% vs. 6%, P=0.009) increased significantly. The mean surgery times across the two periods were comparable. The number of secondary complex operations increased from 12 (18%) to 14 (38%) (P=0.028) during the COVID 19-period. The number of 2-week postoperative readmission decreased from 10 (15%) to 1 (3%) (P=0.049). No participants contracted during the COVID-19 period.ConclusionsUrological tube-related emergencies have been found to have a higher incidence and require more complicated and dangerous operations during the COVID-19 pandemic. However, the optimized management strategies introduced in this study are efficient, and safe for both urologists and patients. 相似文献
15.
Hyun Cheol Chung MD PhD Yoon-Koo Kang MD PhD Zhendong Chen MD Yuxian Bai MD Wan Zamaniah Wan Ishak MD Byoung Yong Shim MD Young Lee Park MD Dong-Hoe Koo MD PhD Jianwei Lu MD Jianming Xu MD Hong Jae Chon MD Li-Yuan Bai MD Shan Zeng MD Ying Yuan MD Yen-Yang Chen MD Kangsheng Gu MD Wen Yan Zhong PhD Shu Kuang MD Chie-Schin Shih MD Shu-Kui Qin MD PhD 《Cancer》2022,128(5):995-1003
16.
17.
18.
目的探讨前列腺原发胃肠道外间质瘤诊治要点。
方法回顾性分析我院2017年9月诊治的1例高危原发性前列腺胃肠道外间质瘤临床病理特征资料、随访情况,总结现有文献讨论总结本病诊治心得。
结果65岁男性,因"前列腺电切术后2年,反复血尿3个月余"入院。术前MRI考虑为来源不清的盆腔巨大实性占位(115 mm×105 mm×85 mm),经直肠穿刺诊断为梭形细胞来源的肿瘤。行盆腔肿瘤切除+膀胱前列腺腺切除+盆腔淋巴结清扫术+Bricker术。术后病理提示为前列腺原发胃肠道外间质瘤[CD117(+);Dog1(+);CD34(+);PSA(+);AR(+);P504s(+);Ki-67(2%)]。术后肿瘤组织全外显子测序提示为C-Kit基因(Exon 11 p.Q556-V560del)存在明显临床意义突变,筛选靶向药物甲磺酸伊马替尼+比卡鲁胺(PSA平稳后停用)口服,术后随访18个月无肿瘤复发及不良并发症。
结论前列腺原发胃肠道外间质瘤罕见,需与前列腺其他良恶性肿瘤相鉴别诊断。全外显子测序了解其发病高危基因,同时筛选药物辅助治疗可使患者生存获益。 相似文献
19.
为探索以器官-系统为中心的整合课程的教学改革,本项目在“5+3”医学生中进行了针对感官系统的临床技能培训新体系建设。根据当前医学教育改革发展的趋势和要求,结合目前临床技能教学的现状,项目整合了包括耳鼻咽喉科、眼科及皮肤科的基础与临床教学内容,设计了新的临床技能培训体系,其中包括编写新的教材,制定新的教学大纲,由专门的教学组负责实施,培训方式包括模拟训练和床旁实战训练,考核方法包括操作能力考核和临床病例考核,培训内容则涵盖各专业常规操作技能。经过实践运用,证实该培训体系能快速有效地提升学生的临床操作技能,取得了良好的教学效果。 相似文献